Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | +14.29% | -61.90% | -83.67% |
02-01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 19/06/07 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/08/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 19/06/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,692,473 | 0 | 2,358,537 ( 35.24 %) | 87.87 % |
Stock B | 1 | 522,529,811 | 465,030,028 ( 89.00 %) | 8,516,056 ( 1.630 %) |
Company contact information
Innovation Pharmaceuticals, Inc.
301 Edgewater Place Suite 100
01880, Wakefield
+
http://www.ipharminc.comSector
1st Jan change | Capi. | |
---|---|---|
-83.67% | 423K | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- IPIX Stock
- Company Innovation Pharmaceuticals Inc.